Thermogenesis Holdings Inc
General ticker "THMO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.2K
Thermogenesis Holdings Inc does not follow the US Stock Market performance with the rate: -40.8%.
Estimated limits based on current volatility of 99.3%: low 0.00$, high 0.00$
Factors to consider:
- China accounted for 18.9% of revenue in the fiscal year ended 2022-12-31
- US accounted for 63.4% of revenue in the fiscal year ended 2022-12-31
- Current price 100.0% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.03$, 7.03$]
- 2023-12-31 to 2024-12-30 estimated range: [1.27$, 4.04$]
Financial Metrics affecting the THMO estimates:
- Negative: Non-GAAP EPS, $ of -24.03 <= 0.10
- Negative: Operating profit margin, % of -37.14 <= 1.03
- Negative: Operating cash flow per share per price, % of -73.02 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -7.05 <= 3.85
- Negative: Industry earnings per price (median), % of -5.29 <= 1.31
- Negative: Interest expense per share, $ of 10.19 > 0.74
- Negative: Industry operating profit margin (median), % of -32.90 <= 2.14
- Negative: Industry inventory ratio change (median), % of 2.06 > 0.49
Short-term THMO quotes
Long-term THMO plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $9.74MM | $9.29MM | $10.48MM |
| Operating Expenses | $18.64MM | $16.52MM | $16.68MM |
| Operating Income | $-8.89MM | $-7.23MM | $-6.19MM |
| Non-Operating Income | $-7.92MM | $-4.65MM | $-5.62MM |
| Interest Expense | $7.91MM | $6.10MM | $5.62MM |
| R&D Expense | $2.48MM | $2.21MM | $1.66MM |
| Income(Loss) | $-16.81MM | $-11.88MM | $-11.81MM |
| Profit(Loss) | $-16.81MM | $-11.88MM | $-11.81MM |
| Stockholders Equity | $5.80MM | $3.83MM | $4.30MM |
| Inventory | $5.88MM | $5.37MM | $3.33MM |
| Assets | $20.86MM | $20.65MM | $19.39MM |
| Operating Cash Flow | $-14.39MM | $-6.62MM | $-7.28MM |
| Capital expenditure | $0.02MM | $0.09MM | $0.40MM |
| Investing Cash Flow | $-0.02MM | $-0.09MM | $-0.40MM |
| Financing Cash Flow | $17.42MM | $6.83MM | $4.59MM |
| Earnings Per Share* | $-117.20 | $-43.41 | $-20.45 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.